vimarsana.com

Page 16 - விரிவாக்கப்பட்டது ப்ரோக்ர்யாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vietnam continues AstraZeneca rollout despite blood clot concern

Vietnam to receive another 1 3 million COVID-19 vaccine doses this month

5 people develop complications from AstraZeneca Covid-19 vaccine

5 people develop complications from AstraZeneca Covid-19 vaccine By Le Nga   March 10, 2021 | 12:40 pm GMT+7 A medical staff prepares to inject the AstraZeneca Covid-19 vaccine for frontline workers at the National Hospital for Tropical Diseases, Hanoi, March 8 2021. Photo by VnExpress/Giang Huy. Five of the 522 medical workers and others who got the AstraZeneca Covid-19 vaccine have developed minor complications and are being treated in hospital. Two suffered from anaphylaxis and three others developed diarrhea, allergies and low pulse pressure, according to the national Expanded Program on Immunization. They are being treated and in stable condition. The vaccination campaign began on Monday and hundreds of medical staff in Hanoi, HCMC and Hai Duong and Gia Lai provinces have received the first dose of the vaccine developed by the British-Swedish company in collaboration with Oxford University.

Vietnam records side effects after COVID-19 vaccination

Wednesday, March 10, 2021, 13:38 GMT+7 A medical worker prepares a shot of AstraZeneca/Oxford COVID-19 vaccine at the National Hospital for Tropical Diseases – Dong Anh District Branch in Hanoi, March 8, 2021. Photo: Nam Tran / Tuoi Tre Five people who were among the first in Vietnam to be injected with a COVID-19 vaccine developed by AstraZeneca/Oxford have experienced side effects, according to the Ministry of Health. Since the launch of the COVID-19 vaccination  on Monday, a total of 522 medical workers, who are directly treating COVID-19 patients, conducting sampling and testing, and performing contact-tracing tasks, have received the shots, according to the Expanded Program on Immunization.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.